Advertisement






Click here for more guidelines.
CME Topic Collections Past Issues Search Current Issue Home
     

J Am Coll Cardiol, 2001; 38:1340-1347
© 2001 by the American College of Cardiology Foundation
This Article
Right arrow Abstract Freely available
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Zalai, C. V.
Right arrow Articles by Lucas, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Zalai, C. V.
Right arrow Articles by Lucas, A.

Increased circulating monocyte activation in patients with unstable coronary syndromes

Christian V. Zalai, MSc* {dagger}, M. Dean Kolodziejczyk, MSc* §, Linda Pilarski, PhD||, Alexander Christov, PhD*, Patric N. Nation, DVM, Marita Lundstrom-Hobman, PhD§, Wayne Tymchak, MD, FRCP(C), FACC#, Vladimir Dzavik, MD, FRCP(C), FACC# **, Dennis P. Humen, MD, FRCP(C), FACC# ||, William J. Kostuk, MD, FRCP(C), FACC{ddagger}, George Jablonsky, MD, FRCP(C), FACC{ddagger}, Peter W. Pflugfelder, MD, FRCP(C), FACC{ddagger}, James E. Brown, MD, FRCP(C), FACC{ddagger} and Alexandra Lucas, MD, FRCP(C), FACC*,* {dagger} § #

* John P. Robarts Research Institute, University of Western Ontario, London, Ontario, Canada
{dagger} Department of Microbiology and Immunology, University of Western Ontario, London, Ontario, Canada
{ddagger} Department of Medicine, University of Western Ontario, London, Ontario, Canada
§ Cardiovascular Research Group, University of Alberta, Edmonton, Alberta, Canada
|| Department of Oncology, University of Alberta, Edmonton, Alberta, Canada
Department of Lab Animal Sciences, University of Alberta, Edmonton, Alberta, Canada
# Department of Medicine, University of Alberta, Edmonton, Alberta, Canada
** Department of Medicine, University of Toronto, Toronto, Ontario, Canada



View larger version (58K):

[in a new window]
 
Figure 1 (A) Immunostaining for CD14, a monocyte-specific marker, demonstrated migration of mononuclear cell (MC) isolated from patients with unstable angina (UA) through a Matrigel-coated filter. (B) Bar graphs demonstrate a significant increase (p < 0.05) in the mean migration rates of MCs isolated from patients with UA on comparison with cells isolated from patients with stable angina or normal coronary arteries. No significant shifts in migration rates were detected for lymphocytes. (C) A significant increase in cellular migration rates was detected after treatment with lipopolysaccharide (LPS) for cells isolated from normal donors (p < 0.001) but not for cells isolated from patients with unstable coronary artery disease. Relative MC migration count was obtained by dividing MC cell counts at each LPS dose by untreated control counts. Results are presented as mean cell counts per high power field of all donor samples within a category ± SE. *p ≤ 0.05. AMI = acute myocardial infarction; CCS = Canadian Cardiovascular Society; L = lymphocyte; M = monocyte; N = normal; P = pore; SA = stable angina.

 


View larger version (42K):

[in a new window]
 
Figure 2 Membrane fluidity assays: A significant increase in membrane fluidity is evident in pyrene fluorescence emission spectra recorded from labeled mononuclear cells (MC) after treatment with thrombin (A). Patients with unstable angina (UA) demonstrated a significantly altered membrane fluidity profile (B) on comparison with cells obtained from normal individuals (p < 0.01), patients with stable angina (p < 0.001), and patients with acute myocardial infarction (MI) (p < 0.05). Thrombin treatment resulted in a significant change in the measured membrane fluidity of cells obtained from normal individuals (p < 0.05), but did not significantly alter the fluidity of cells obtained from patients with UA (C). Saline-treated cells (striped bars) obtained from patients with UA show a similar profile to those thrombin-treated cells (black bars) obtained from normal individuals. Data represent the mean Iexc/Imon ratios ± SE. Cells were grouped according to the Canadian Cardiovascular Society guidelines. *p ≤ 0.05.

 


View larger version (44K):

[in a new window]
 
Figure 3 Significant increases in serum levels of soluble CD14 (sCD14) (p < 0.01) were found in patients with unstable coronary artery disease as compared to normal donors and patients with acute myocardial infarction (MI). The level of sCD14 did not differ significantly from individuals with stable angina (p = 0.06), but did show a trend toward an increase. Data represent the mean level of sCD14 expressed in g/ml; error bars represent SE. UA = unstable angina.

 




 
  CME Topic Collections Past Issues Search Current Issue Home

Advertisement